Related references
Note: Only part of the references are listed.Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain
Chiaki Miyazaki et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
T-cell help dependence of memory CD8+ T-cell expansion upon vaccinia virus challenge relies on CD40 signaling
Gregor Bedenikovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Truncation of gene F5L partially masks rescue of vaccinia virus strain MVA growth on mammalian cells by restricting plaque size
Bianca M. Dobson et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy
Rebecca P. Sumner et al.
JOURNAL OF GENERAL VIROLOGY (2013)
The Novel Replication-defective Vaccinia Virus (Tiantan Strain)-based Hepatitis C Virus Vaccine Induces Robust Immunity in Macaques
Bo Wen et al.
MOLECULAR THERAPY (2013)
Deletion of C7L and K1L Genes Leads to Significantly Decreased Virulence of Recombinant Vaccinia Virus TianTan
Zheng Liu et al.
PLOS ONE (2013)
Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization
Liu CunXia et al.
SCIENCE CHINA-LIFE SCIENCES (2013)
Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis
Zhang Ying et al.
SCIENCE CHINA-LIFE SCIENCES (2013)
Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain
Yuhang Wang et al.
ANTIVIRAL RESEARCH (2012)
A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines
Elina O. Erra et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China
Qiang Liu et al.
PLOS ONE (2012)
Optimisation of Prime-Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine
Hong Chen et al.
PLOS ONE (2012)
Comparison on Virulence and Immunogenicity of Two Recombinant Vaccinia Vaccines, Tian Tan and Guang9 Strains, Expressing the HIV-1 Envelope Gene
Rong Zhu et al.
PLOS ONE (2012)
Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
Baoying Huang et al.
VIROLOGY JOURNAL (2012)
Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis
Wang Ling-yun et al.
VACCINE (2011)
The eradication of smallpox - An overview of the past, present, and future
Donald A. Henderson
VACCINE (2011)
Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18
Li Zhao et al.
VIROLOGY JOURNAL (2011)
Activation of Human Dendritic Cells by Recombinant Modified Vaccinia Virus Ankara Vectors Encoding Survivin and IL-2 Genes In Vitro
Ran Tao et al.
HUMAN GENE THERAPY (2010)
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
Jeffrey R. Currier et al.
PLOS ONE (2010)
One time intranasal vaccination with a modified vaccinia Tiantan strain MVTTZCI protects animals against pathogenic viral challenge
Wenbo Yu et al.
VACCINE (2010)
Modern Uses of Electron Microscopy for Detection of Viruses
Cynthia S. Goldsmith et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Application of Bioluminescence Imaging to the Prediction of Lethality in Vaccinia Virus-Infected Mice
Marina Zaitseva et al.
JOURNAL OF VIROLOGY (2009)
Elucidating and Minimizing the Loss by Recombinant Vaccinia Virus of Human Immunodeficiency Virus Gene Expression Resulting from Spontaneous Mutations and Positive Selection
Linda S. Wyatt et al.
JOURNAL OF VIROLOGY (2009)
A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
Xiaoxing Huang et al.
PLOS ONE (2009)
Comparison of Monkeypox Viruses Pathogenesis in Mice by In Vivo Imaging
Jorge E. Osorio et al.
PLOS ONE (2009)
A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice
Yao Deng et al.
VACCINE (2009)
SARS-CoV Spike Proteins Expressed by the Vaccinia Virus Tiantan Strain: Secreted SQ Protein Induces Robust Neutralization Antibody in Mice
Kexia Yan et al.
VIRAL IMMUNOLOGY (2009)
Immunogenicity comparison between codon optimized HIV-1CRF BC_07 gp140 and gp145 vaccines
Lianxing Liu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells
Jye-Chian Hsiao et al.
JOURNAL OF VIROLOGY (2006)
Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain
Q Fang et al.
VIROLOGY (2005)
A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor
Ming-Bo Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 α and vaccinia viral translation in apoptotic HeLa cells
JC Hsiao et al.
VIROLOGY (2004)
Share Paper
